Search PubMed⌕ Search

Biomedical subjects

E Castano

Publications and source records attributed to E Castano.

5 recordsLinked to original sources

Comparison of clinical and pathological phenotypes in two ethnically and geographically unrelated pedigrees segregating an equivalent presenilin 1 mutation.

At least 30 different missense mutations have been identified within the presenilin 1 (PS1) gene in pedigrees transmitting familial Alzheimer's disease. The authors investigated the clinical and pathological features of affected members of two pedigrees segregating a PS1 Met146Leu mutation. Genetic relationships between these pedigrees can be effectively excluded on the basis of genealogical data and the fact that although the amino acid substitution is identical, the nucleotide mutations are different. The clinical picture shows remarkable similarities in the neurological and the neuropathological findings between the two pedigrees. This general clinical and pathological concordance argues that much of the disease phenotype arises directly from the effects of the amino acid substitution within the PS1 protein itself. Clinical differences could arise from a direct effect of the difference in base sequence or, alternatively, from the effect of genetic or environmental modifiers.

Alzheimer Disease↗

Cerebrospinal fluid inhibits Alzheimer beta-amyloid fibril formation in vitro.

Alzheimer's disease is characterized by the deposition of beta-protein (A beta) as amyloid. Recently, it was found that A beta is a normal component of serum and cerebrospinal fluid. Synthetic peptides homologous to A beta form amyloid-like fibrils spontaneously in water or physiological solutions. Using a peptide homologous to A beta 1-40, we find that fibril formation is inhibited by the presence of cerebrospinal fluid.

Alzheimer Disease↗

[Native NC2 selectively represses incorrect transcription initiation].

Transcriptional regulation depends on the appropriate set of positive and negative signals that provide correct gene expression. Studies in eukaryotic gene expression have shown NC2 to be a general repressor of transcription which blocks the interaction between TFIIB and TBP. However, during the last few years NC2 has been found to bind the transcriptionally active promoters and interact with several positive transcription factors. These data suggested a controversial role of NC2 in transcription. Using in vitro transcription on minimal LTR promoter of HIV-1, we show that removal of NC2 from HeLa nuclear extract increases the yield of transcripts as well as unspecific transcription initiation in a template amount dependent manner. Fractions of HeLa nuclear extract containing NC2 can restore basal transcription repression and precise selection of transcription initiation point. This points to a new role for NC2 as a repressor of inaccurate transcription initiation that allows specific transcription to take place.

Animals↗